Month-6 primary outcomes of the READ-3 study (Ranibizumab for Edema of the mAcula in Diabetes-Protocol 3 with high dose)

D. V. Do, Y. J. Sepah, D. Boyer, D. Callanan, R. Gallemore, M. Bennett, D. M. Marcus, L. Halperin, M. A. Sadiq, N. Rajagopalan, P. A. Campochiaro, Q. D. Nguyen

Research output: Contribution to journalArticlepeer-review

20 Scopus citations

Fingerprint Dive into the research topics of 'Month-6 primary outcomes of the READ-3 study (Ranibizumab for Edema of the mAcula in Diabetes-Protocol 3 with high dose)'. Together they form a unique fingerprint.

Medicine & Life Sciences